| Schedule of Consolidated VIE and Subsidiaries of the VIE |
As of June 30, 2026, the details of the Company’s major subsidiaries, consolidated VIE and the subsidiaries of the VIE are as follows: | | | Date of | | Place of | | Percentage of ownership by the Company | | | | Entity | | incorporation | | incorporation | | Direct | | Indirect | | Principal activities | | Subsidiaries: | | | | | | | | | | | | Pom (HK) | | March 12, 2021 | | Hong Kong | | 100% owned by the Company | | — | | Investment holding | | Guangzhou WFOE | | April 6, 2021 | | PRC | | 100% owned by Pom (HK) | | — | | WFOE, Investment holding | | Guangzhou Li Luo Technology Co., Ltd. | | February 4, 2026 | | PRC | | 100% owned by Guangzhou WFOE | | — | | Online hospital service | | | | | | | | | | | | | | VIE: | | | | | | | | | | | | Qilekang Digital Health | | January 12, 2010 | | PRC | | — | | 94.86% | | Online hospital service and pharmaceutical supply chain | | VIE’s subsidiaries: | | | | | | | | | | | | Guangzhou Qilekang Modern Pharmaceutical Logistics Co., Ltd. (“Modern Logistics”) | | October 24, 2002 | | PRC | | — | | 100% owned by Qilekang Digital Health | | Drugs wholesale | | Hangzhou Qilekang Pharmaceutical Co., Ltd. (“Hangzhou Qilekang”) | | July 27, 2016 | | PRC | | — | | 100% owned by Qilekang Digital Health | | Offline retail pharmacy and drugs wholesale | | Nanjing Qilekang Pharmaceutical Co., Ltd. (“Nanjing Qilekang”) | | November 13, 2018 | | PRC | | — | | 80% owned by Qilekang Digital Health | | Drugs sales | | Suzhou Qilekang Pharmaceutical Co., Ltd. (“Suzhou Qilekang”) | | September 2, 2024 | | PRC | | — | | 100% owned by Qilekang Digital Health | | Drugs sales | | Guangzhou Qilekang Cloud Technology Co., Ltd. (“Guangzhou Cloud Tech”) | | November 5, 2024 | | PRC | | — | | 100% owned by Qilekang Digital Health | | Online service and pharmaceutical supply chain | | Guangzhou Pomegranate Cloud Pharma Health Industry Technology Co., Ltd. | | February 20, 2025 | | PRC | | — | | 100% owned by Qilekang Cloud Technology | | Drugs sales | | Guangzhou Wanggang International Medical Management Co., Ltd. | | September 26, 2017 | | PRC | | — | | 100% owned by Qilekang Cloud Technology | | Drugs sales |
|
| Schedule of Financial Information for the VIE |
The following tables represent the selected financial information for the VIE as of December 31, 2025 and June 30, 2026 and for the six months ended June 30, 2025 and 2026. | | | As of December 31, 2025 | | | As of June 30, 2026 | | | As of June 30, 2026 | | | | | RMB | | | RMB | | | US$ | | | Current assets | | | 46,138,392 | | | | 67,077,820 | | | | 9,886,047 | | | Non-current assets | | | 2,590,800 | | | | 2,378,273 | | | | 350,515 | | | Total assets | | | 48,729,192 | | | | 69,456,093 | | | | 10,236,562 | | | Current liabilities | | | 264,182,042 | | | | 393,222,831 | | | | 57,953,875 | | | Non-current liabilities | | | 370,685,951 | | | | 371,268,969 | | | | 54,718,275 | | | Total liabilities | | | 634,867,993 | | | | 764,491,800 | | | | 112,672,150 | | | Net deficit | | | (586,138,801 | ) | | | (695,035,707 | ) | | | (102,435,588 | ) | | | | For the Six Months Ended June 30, | | | | | 2025 | | | 2026 | | | 2026 | | | | | RMB | | | RMB | | | US$ | | | Net revenues | | | 174,469,851 | | | | 198,904,347 | | | | 29,314,873 | | | Net loss | | | (19,885,492 | ) | | | (108,563,975 | ) | | | (16,000,350 | ) | | | | For the Six Months Ended June 30, | | | | | 2025 | | | 2026 | | | 2026 | | | | | RMB | | | RMB | | | US$ | | | Net cash (used in) provided by operating activities | | | (16,775,572 | ) | | | 2,262,292 | | | | 333,421 | | | Net cash used in investing activities | | | (512,200 | ) | | | (63,078 | ) | | | (9,297 | ) | | Net cash provided by (used in) financing activities | | | 15,270,864 | | | | (4,678,408 | ) | | | (689,512 | ) |
|